Investor Tips

Icahn v. Hindenburg: Who’s Right?

Products You May Like

We analyze Hindenburg’s claims of overvaluation, Ponzi-like dividends, and inflated assets at Ichan Enterprises.

#US #Dividends #Ponzi #Research #Short #Short Seller #Stocks #Stock Market #Equities #Investing #Trading #IEP #TPOU #PSHZF #SPX #NDX

Products You May Like

Articles You May Like

Once high-flying Bluebird Bio sells itself to private equity after tough times for the gene therapy maker
Congress Must Cement Full R&D Tax Expensing for Economic Growth
Sony shares surge over 10% after it forecasts stronger revenue and profit for fiscal year 2024
Southwest Airlines to slash 15% of corporate jobs in ‘unprecedented’ move to cut costs
Steve Cohen says tariffs and DOGE’s cuts are negative for economy, market correction could be soon